Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

IOTECH Editorial Board


Senior Editors

  • George Coukos – Lausanne, Switzerland

Section Editors

Neoantigens, tumour-infiltrating lymphocytes
  • Michal Bassani – Lausanne, Switzerland
Cell therapies and cytokines
  • Alena Gros – Barcelona, Spain
Adoptive cell therapy and gene therapy
  • Johanna Olweus – Oslo, Norway
T cell diagnostics and isolation platforms
  • Sine Reker Hadrup – Copenhagen, Denmark
Genomics, tumor mutational burden, tumor heterogeneity
  • Samra Turajlic - London, UK
  • Li Tang – Lausanne, Switzerland
Biomarkers and novel IO targets
  • Daniela Thommen – Amsterdam, Netherlands

Board members

  • Tim Chan – New York, USA
  • Charles C. Drake - New York, USA
  • David Gfeller – Lausanne, Switzerland
  • Siwen Hu-Lieskovan – Salt Lake City, USA
  • Keith Kerr – Aberdeen, UK
  • Arthur M. Krieg - Cambridge, USA
  • Aurelien Marabelle - Paris, France
  • Alexander Menzies – Sydney, Australia
  • Michael Milone - Philadephia, USA
  • Thomas Powles – London, UK
  • Antoni Ribas – Los Angeles, USA
  • Padmanee Sharma – Houston, Texas
  • Daniel E. Speiser – Lausanne, Switzerland
  • Charles Swanton – London, UK
  • Michele Teng – Brisbane, Australia
  • Jennifer J. Wargo – Houston, USA
  • Anna M. Wu – Duarte, USA

Last update: June 2021

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.